GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
BATF
|
ENSG00000156127.6 | basic leucine zipper ATF-like transcription factor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
BATF | hg19_v2_chr14_+_75988851_75988903 | -0.23 | 6.1e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_223889285 | 54.48 |
ENST00000433674.2
|
CAPN2
|
calpain 2, (m/II) large subunit |
chr6_-_31704282 | 39.29 |
ENST00000375784.3
ENST00000375779.2 |
CLIC1
|
chloride intracellular channel 1 |
chr11_-_33744487 | 38.26 |
ENST00000426650.2
|
CD59
|
CD59 molecule, complement regulatory protein |
chr5_+_159848854 | 37.54 |
ENST00000517480.1
ENST00000520452.1 ENST00000393964.1 |
PTTG1
|
pituitary tumor-transforming 1 |
chr11_-_33743952 | 36.14 |
ENST00000534312.1
|
CD59
|
CD59 molecule, complement regulatory protein |
chr6_+_63921399 | 34.58 |
ENST00000356170.3
|
FKBP1C
|
FK506 binding protein 1C |
chr16_-_69760409 | 32.59 |
ENST00000561500.1
ENST00000439109.2 ENST00000564043.1 ENST00000379046.2 ENST00000379047.3 |
NQO1
|
NAD(P)H dehydrogenase, quinone 1 |
chr2_+_10262442 | 30.14 |
ENST00000360566.2
|
RRM2
|
ribonucleotide reductase M2 |
chr1_-_151965048 | 30.05 |
ENST00000368809.1
|
S100A10
|
S100 calcium binding protein A10 |
chr17_-_79481666 | 28.22 |
ENST00000575659.1
|
ACTG1
|
actin, gamma 1 |
chr4_-_84035905 | 27.75 |
ENST00000311507.4
|
PLAC8
|
placenta-specific 8 |
chr3_-_149095652 | 27.61 |
ENST00000305366.3
|
TM4SF1
|
transmembrane 4 L six family member 1 |
chr3_-_81792780 | 27.41 |
ENST00000489715.1
|
GBE1
|
glucan (1,4-alpha-), branching enzyme 1 |
chr2_-_106013400 | 27.22 |
ENST00000409807.1
|
FHL2
|
four and a half LIM domains 2 |
chr5_+_135394840 | 27.16 |
ENST00000503087.1
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa |
chr4_-_174254823 | 26.84 |
ENST00000438704.2
|
HMGB2
|
high mobility group box 2 |
chr5_+_159848807 | 26.20 |
ENST00000352433.5
|
PTTG1
|
pituitary tumor-transforming 1 |
chr8_+_55047763 | 25.65 |
ENST00000260102.4
ENST00000519831.1 |
MRPL15
|
mitochondrial ribosomal protein L15 |
chr15_-_60690163 | 25.02 |
ENST00000558998.1
ENST00000560165.1 ENST00000557986.1 ENST00000559780.1 ENST00000559467.1 ENST00000559956.1 ENST00000332680.4 ENST00000396024.3 ENST00000421017.2 ENST00000560466.1 ENST00000558132.1 ENST00000559113.1 ENST00000557906.1 ENST00000558558.1 ENST00000560468.1 ENST00000559370.1 ENST00000558169.1 ENST00000559725.1 ENST00000558985.1 ENST00000451270.2 |
ANXA2
|
annexin A2 |
chr5_+_73980965 | 24.08 |
ENST00000261416.7
|
HEXB
|
hexosaminidase B (beta polypeptide) |
chr22_+_23241661 | 23.89 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
chr11_-_2950642 | 23.70 |
ENST00000314222.4
|
PHLDA2
|
pleckstrin homology-like domain, family A, member 2 |
chr6_+_63921351 | 22.79 |
ENST00000370659.1
|
FKBP1C
|
FK506 binding protein 1C |
chr1_-_24126023 | 22.61 |
ENST00000429356.1
|
GALE
|
UDP-galactose-4-epimerase |
chr2_-_85637459 | 22.56 |
ENST00000409921.1
|
CAPG
|
capping protein (actin filament), gelsolin-like |
chr20_+_47835884 | 22.34 |
ENST00000371764.4
|
DDX27
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 27 |
chr5_+_65222384 | 22.17 |
ENST00000380943.2
ENST00000416865.2 ENST00000380939.2 ENST00000380936.1 ENST00000380935.1 |
ERBB2IP
|
erbb2 interacting protein |
chr6_+_44194762 | 22.09 |
ENST00000371708.1
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1 |
chr9_+_75766652 | 21.40 |
ENST00000257497.6
|
ANXA1
|
annexin A1 |
chr1_-_225616515 | 21.31 |
ENST00000338179.2
ENST00000425080.1 |
LBR
|
lamin B receptor |
chr6_-_138428613 | 20.67 |
ENST00000421351.3
|
PERP
|
PERP, TP53 apoptosis effector |
chr11_-_64013288 | 20.54 |
ENST00000542235.1
|
PPP1R14B
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
chr7_-_87856303 | 20.50 |
ENST00000394641.3
|
SRI
|
sorcin |
chr14_+_35747825 | 20.48 |
ENST00000540871.1
|
PSMA6
|
proteasome (prosome, macropain) subunit, alpha type, 6 |
chr1_+_26605618 | 20.26 |
ENST00000270792.5
|
SH3BGRL3
|
SH3 domain binding glutamic acid-rich protein like 3 |
chr12_+_96252706 | 20.23 |
ENST00000266735.5
ENST00000553192.1 ENST00000552085.1 |
SNRPF
|
small nuclear ribonucleoprotein polypeptide F |
chr1_-_113247543 | 19.80 |
ENST00000414971.1
ENST00000534717.1 |
RHOC
|
ras homolog family member C |
chr1_+_158979686 | 19.55 |
ENST00000368132.3
ENST00000295809.7 |
IFI16
|
interferon, gamma-inducible protein 16 |
chr1_-_225615599 | 19.27 |
ENST00000421383.1
ENST00000272163.4 |
LBR
|
lamin B receptor |
chr9_+_42704004 | 19.22 |
ENST00000457288.1
|
CBWD7
|
COBW domain containing 7 |
chr2_+_90060377 | 19.16 |
ENST00000436451.2
|
IGKV6D-21
|
immunoglobulin kappa variable 6D-21 (non-functional) |
chr1_-_209824643 | 19.07 |
ENST00000391911.1
ENST00000415782.1 |
LAMB3
|
laminin, beta 3 |
chr1_+_26606608 | 18.94 |
ENST00000319041.6
|
SH3BGRL3
|
SH3 domain binding glutamic acid-rich protein like 3 |
chr10_+_17270214 | 18.75 |
ENST00000544301.1
|
VIM
|
vimentin |
chr12_+_69979113 | 18.61 |
ENST00000299300.6
|
CCT2
|
chaperonin containing TCP1, subunit 2 (beta) |
chr7_-_7680601 | 18.54 |
ENST00000396682.2
|
RPA3
|
replication protein A3, 14kDa |
chr1_+_158979792 | 18.47 |
ENST00000359709.3
ENST00000430894.2 |
IFI16
|
interferon, gamma-inducible protein 16 |
chr15_+_80364901 | 18.19 |
ENST00000560228.1
ENST00000559835.1 ENST00000559775.1 ENST00000558688.1 ENST00000560392.1 ENST00000560976.1 ENST00000558272.1 ENST00000558390.1 |
ZFAND6
|
zinc finger, AN1-type domain 6 |
chr2_-_152146385 | 18.14 |
ENST00000414946.1
ENST00000243346.5 |
NMI
|
N-myc (and STAT) interactor |
chr1_+_158900568 | 18.00 |
ENST00000458222.1
|
PYHIN1
|
pyrin and HIN domain family, member 1 |
chr6_-_24667180 | 17.86 |
ENST00000545995.1
|
TDP2
|
tyrosyl-DNA phosphodiesterase 2 |
chr3_+_33155525 | 17.83 |
ENST00000449224.1
|
CRTAP
|
cartilage associated protein |
chr1_-_152009460 | 17.75 |
ENST00000271638.2
|
S100A11
|
S100 calcium binding protein A11 |
chr6_-_24666819 | 17.66 |
ENST00000341060.3
|
TDP2
|
tyrosyl-DNA phosphodiesterase 2 |
chr14_+_55590646 | 17.54 |
ENST00000553493.1
|
LGALS3
|
lectin, galactoside-binding, soluble, 3 |
chr17_+_18625336 | 17.53 |
ENST00000395671.4
ENST00000571542.1 ENST00000395672.2 ENST00000414850.2 ENST00000424146.2 |
TRIM16L
|
tripartite motif containing 16-like |
chr5_+_65222299 | 17.45 |
ENST00000284037.5
|
ERBB2IP
|
erbb2 interacting protein |
chr10_+_106014468 | 17.32 |
ENST00000369710.4
ENST00000369713.5 ENST00000445155.1 |
GSTO1
|
glutathione S-transferase omega 1 |
chr7_+_73106926 | 17.26 |
ENST00000453316.1
|
WBSCR22
|
Williams Beuren syndrome chromosome region 22 |
chr2_-_85641162 | 17.25 |
ENST00000447219.2
ENST00000409670.1 ENST00000409724.1 |
CAPG
|
capping protein (actin filament), gelsolin-like |
chr22_+_23046750 | 17.17 |
ENST00000390307.2
|
IGLV3-22
|
immunoglobulin lambda variable 3-22 (gene/pseudogene) |
chr3_+_30647994 | 16.95 |
ENST00000295754.5
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa) |
chr3_+_30648066 | 16.93 |
ENST00000359013.4
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa) |
chr11_+_101983176 | 16.63 |
ENST00000524575.1
|
YAP1
|
Yes-associated protein 1 |
chr2_-_89417335 | 16.61 |
ENST00000490686.1
|
IGKV1-17
|
immunoglobulin kappa variable 1-17 |
chr2_+_201981527 | 16.59 |
ENST00000441224.1
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
chr1_+_156084461 | 16.50 |
ENST00000347559.2
ENST00000361308.4 ENST00000368300.4 ENST00000368299.3 |
LMNA
|
lamin A/C |
chr1_+_158979680 | 16.46 |
ENST00000368131.4
ENST00000340979.6 |
IFI16
|
interferon, gamma-inducible protein 16 |
chr12_-_53343602 | 16.43 |
ENST00000546897.1
ENST00000552551.1 |
KRT8
|
keratin 8 |
chr11_-_64013663 | 16.38 |
ENST00000392210.2
|
PPP1R14B
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
chr17_-_73150629 | 16.27 |
ENST00000356033.4
ENST00000405458.3 ENST00000409753.3 |
HN1
|
hematological and neurological expressed 1 |
chr8_-_124037890 | 16.27 |
ENST00000519018.1
ENST00000523036.1 |
DERL1
|
derlin 1 |
chr5_+_138089100 | 16.18 |
ENST00000520339.1
ENST00000355078.5 ENST00000302763.7 ENST00000518910.1 |
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa |
chr12_+_123237321 | 16.17 |
ENST00000280557.6
ENST00000455982.2 |
DENR
|
density-regulated protein |
chr13_+_28195988 | 16.12 |
ENST00000399697.3
ENST00000399696.1 |
POLR1D
|
polymerase (RNA) I polypeptide D, 16kDa |
chr4_-_84035868 | 15.94 |
ENST00000426923.2
ENST00000509973.1 |
PLAC8
|
placenta-specific 8 |
chr19_+_14672755 | 15.90 |
ENST00000594545.1
|
TECR
|
trans-2,3-enoyl-CoA reductase |
chr2_+_90198535 | 15.80 |
ENST00000390276.2
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
chr12_+_75874460 | 15.80 |
ENST00000266659.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
chr11_-_33744256 | 15.64 |
ENST00000415002.2
ENST00000437761.2 ENST00000445143.2 |
CD59
|
CD59 molecule, complement regulatory protein |
chr12_-_15104040 | 15.59 |
ENST00000541644.1
ENST00000545895.1 |
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr14_+_20937538 | 15.54 |
ENST00000361505.5
ENST00000553591.1 |
PNP
|
purine nucleoside phosphorylase |
chr1_+_148560843 | 15.37 |
ENST00000442702.2
ENST00000369187.3 |
NBPF15
|
neuroblastoma breakpoint family, member 15 |
chr15_-_85259294 | 15.36 |
ENST00000558217.1
ENST00000558196.1 ENST00000558134.1 |
SEC11A
|
SEC11 homolog A (S. cerevisiae) |
chr2_+_192141611 | 15.35 |
ENST00000392316.1
|
MYO1B
|
myosin IB |
chr1_+_156095951 | 15.34 |
ENST00000448611.2
ENST00000368297.1 |
LMNA
|
lamin A/C |
chrX_+_64887512 | 15.32 |
ENST00000360270.5
|
MSN
|
moesin |
chr3_+_150321068 | 15.04 |
ENST00000471696.1
ENST00000477889.1 ENST00000485923.1 |
SELT
|
Selenoprotein T |
chr6_-_24667232 | 14.98 |
ENST00000378198.4
|
TDP2
|
tyrosyl-DNA phosphodiesterase 2 |
chr2_+_201997492 | 14.93 |
ENST00000494258.1
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
chr1_-_89458636 | 14.83 |
ENST00000370486.1
ENST00000399794.2 |
CCBL2
RBMXL1
|
cysteine conjugate-beta lyase 2 RNA binding motif protein, X-linked-like 1 |
chr12_+_13349650 | 14.78 |
ENST00000256951.5
ENST00000431267.2 ENST00000542474.1 ENST00000544053.1 |
EMP1
|
epithelial membrane protein 1 |
chr3_+_127771212 | 14.75 |
ENST00000243253.3
ENST00000481210.1 |
SEC61A1
|
Sec61 alpha 1 subunit (S. cerevisiae) |
chr2_+_109204909 | 14.53 |
ENST00000393310.1
|
LIMS1
|
LIM and senescent cell antigen-like domains 1 |
chr15_-_85259330 | 14.47 |
ENST00000560266.1
|
SEC11A
|
SEC11 homolog A (S. cerevisiae) |
chr5_+_172386419 | 14.45 |
ENST00000265100.2
ENST00000519239.1 |
RPL26L1
|
ribosomal protein L26-like 1 |
chr2_-_170681324 | 14.29 |
ENST00000409340.1
|
METTL5
|
methyltransferase like 5 |
chr10_+_88854926 | 14.27 |
ENST00000298784.1
ENST00000298786.4 |
FAM35A
|
family with sequence similarity 35, member A |
chr15_-_55563072 | 14.05 |
ENST00000567380.1
ENST00000565972.1 ENST00000569493.1 |
RAB27A
|
RAB27A, member RAS oncogene family |
chr5_+_72143988 | 13.91 |
ENST00000506351.2
|
TNPO1
|
transportin 1 |
chr2_+_201936707 | 13.87 |
ENST00000433898.1
ENST00000454214.1 |
NDUFB3
|
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3, 12kDa |
chr2_-_89513402 | 13.87 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
chr7_+_48128194 | 13.84 |
ENST00000416681.1
ENST00000331803.4 ENST00000432131.1 |
UPP1
|
uridine phosphorylase 1 |
chr3_-_150320937 | 13.79 |
ENST00000479209.1
|
SERP1
|
stress-associated endoplasmic reticulum protein 1 |
chr17_-_8113542 | 13.78 |
ENST00000578549.1
ENST00000535053.1 ENST00000582368.1 |
AURKB
|
aurora kinase B |
chr13_-_41593425 | 13.76 |
ENST00000239882.3
|
ELF1
|
E74-like factor 1 (ets domain transcription factor) |
chr14_-_94854926 | 13.67 |
ENST00000402629.1
ENST00000556091.1 ENST00000554720.1 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr9_-_127177703 | 13.54 |
ENST00000259457.3
ENST00000536392.1 ENST00000441097.1 |
PSMB7
|
proteasome (prosome, macropain) subunit, beta type, 7 |
chr7_+_55177416 | 13.53 |
ENST00000450046.1
ENST00000454757.2 |
EGFR
|
epidermal growth factor receptor |
chr3_-_49066811 | 13.49 |
ENST00000442157.1
ENST00000326739.4 |
IMPDH2
|
IMP (inosine 5'-monophosphate) dehydrogenase 2 |
chr18_-_33702078 | 13.48 |
ENST00000586829.1
|
SLC39A6
|
solute carrier family 39 (zinc transporter), member 6 |
chr15_+_22892663 | 13.39 |
ENST00000313077.7
ENST00000561274.1 ENST00000560848.1 |
CYFIP1
|
cytoplasmic FMR1 interacting protein 1 |
chr7_+_48128316 | 13.33 |
ENST00000341253.4
|
UPP1
|
uridine phosphorylase 1 |
chr12_-_56120865 | 13.31 |
ENST00000548898.1
ENST00000552067.1 |
CD63
|
CD63 molecule |
chr6_-_41909561 | 13.12 |
ENST00000372991.4
|
CCND3
|
cyclin D3 |
chr13_+_53216565 | 12.78 |
ENST00000357495.2
|
HNRNPA1L2
|
heterogeneous nuclear ribonucleoprotein A1-like 2 |
chr7_+_30634297 | 12.77 |
ENST00000389266.3
|
GARS
|
glycyl-tRNA synthetase |
chr2_+_90139056 | 12.77 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
chr7_-_87856280 | 12.75 |
ENST00000490437.1
ENST00000431660.1 |
SRI
|
sorcin |
chr11_+_35198118 | 12.72 |
ENST00000525211.1
ENST00000526000.1 ENST00000279452.6 ENST00000527889.1 |
CD44
|
CD44 molecule (Indian blood group) |
chr6_-_2842087 | 12.72 |
ENST00000537185.1
|
SERPINB1
|
serpin peptidase inhibitor, clade B (ovalbumin), member 1 |
chr3_-_185641681 | 12.71 |
ENST00000259043.7
|
TRA2B
|
transformer 2 beta homolog (Drosophila) |
chr6_-_159239257 | 12.66 |
ENST00000337147.7
ENST00000392177.4 |
EZR
|
ezrin |
chrX_+_23682379 | 12.62 |
ENST00000379349.1
|
PRDX4
|
peroxiredoxin 4 |
chr11_-_65667997 | 12.54 |
ENST00000312562.2
ENST00000534222.1 |
FOSL1
|
FOS-like antigen 1 |
chr2_-_3595547 | 12.52 |
ENST00000438485.1
|
RP13-512J5.1
|
Uncharacterized protein |
chr17_-_7590745 | 12.48 |
ENST00000514944.1
ENST00000503591.1 ENST00000455263.2 ENST00000420246.2 ENST00000445888.2 ENST00000509690.1 ENST00000604348.1 ENST00000269305.4 |
TP53
|
tumor protein p53 |
chr18_+_3247779 | 12.42 |
ENST00000578611.1
ENST00000583449.1 |
MYL12A
|
myosin, light chain 12A, regulatory, non-sarcomeric |
chr11_-_65667884 | 12.29 |
ENST00000448083.2
ENST00000531493.1 ENST00000532401.1 |
FOSL1
|
FOS-like antigen 1 |
chr19_+_49377575 | 12.19 |
ENST00000600406.1
|
PPP1R15A
|
protein phosphatase 1, regulatory subunit 15A |
chr17_+_49230897 | 12.15 |
ENST00000393196.3
ENST00000336097.3 ENST00000480143.1 ENST00000511355.1 ENST00000013034.3 ENST00000393198.3 ENST00000608447.1 ENST00000393193.2 ENST00000376392.6 ENST00000555572.1 |
NME1
NME1-NME2
NME2
|
NME/NM23 nucleoside diphosphate kinase 1 NME1-NME2 readthrough NME/NM23 nucleoside diphosphate kinase 2 |
chr4_-_143227088 | 12.11 |
ENST00000511838.1
|
INPP4B
|
inositol polyphosphate-4-phosphatase, type II, 105kDa |
chr15_-_85259384 | 12.08 |
ENST00000455959.3
|
SEC11A
|
SEC11 homolog A (S. cerevisiae) |
chr3_-_47823298 | 12.07 |
ENST00000254480.5
|
SMARCC1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 |
chr4_+_17616253 | 12.07 |
ENST00000237380.7
|
MED28
|
mediator complex subunit 28 |
chr8_-_102217796 | 12.06 |
ENST00000519744.1
ENST00000311212.4 ENST00000521272.1 ENST00000519882.1 |
ZNF706
|
zinc finger protein 706 |
chr2_+_27435734 | 12.05 |
ENST00000419744.1
|
ATRAID
|
all-trans retinoic acid-induced differentiation factor |
chr19_+_52932435 | 12.01 |
ENST00000301085.4
|
ZNF534
|
zinc finger protein 534 |
chr1_+_174844645 | 11.99 |
ENST00000486220.1
|
RABGAP1L
|
RAB GTPase activating protein 1-like |
chr11_+_18417813 | 11.96 |
ENST00000540430.1
ENST00000379412.5 |
LDHA
|
lactate dehydrogenase A |
chr12_-_76478686 | 11.96 |
ENST00000261182.8
|
NAP1L1
|
nucleosome assembly protein 1-like 1 |
chr11_+_20385327 | 11.95 |
ENST00000451739.2
ENST00000532505.1 |
HTATIP2
|
HIV-1 Tat interactive protein 2, 30kDa |
chr9_+_71819927 | 11.95 |
ENST00000535702.1
|
TJP2
|
tight junction protein 2 |
chr20_-_1373682 | 11.94 |
ENST00000381724.3
|
FKBP1A
|
FK506 binding protein 1A, 12kDa |
chr2_-_89266286 | 11.82 |
ENST00000464162.1
|
IGKV1-6
|
immunoglobulin kappa variable 1-6 |
chr12_+_75874580 | 11.80 |
ENST00000456650.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
chr17_+_1936687 | 11.75 |
ENST00000570477.1
|
DPH1
|
diphthamide biosynthesis 1 |
chr17_+_21191341 | 11.63 |
ENST00000526076.2
ENST00000361818.5 ENST00000316920.6 |
MAP2K3
|
mitogen-activated protein kinase kinase 3 |
chr8_-_67977178 | 11.63 |
ENST00000517736.1
|
COPS5
|
COP9 signalosome subunit 5 |
chr7_+_128399002 | 11.52 |
ENST00000493278.1
|
CALU
|
calumenin |
chr5_-_179051579 | 11.51 |
ENST00000505811.1
ENST00000515714.1 ENST00000513225.1 ENST00000503664.1 ENST00000356731.5 ENST00000523137.1 |
HNRNPH1
|
heterogeneous nuclear ribonucleoprotein H1 (H) |
chr2_+_161993412 | 11.45 |
ENST00000259075.2
ENST00000432002.1 |
TANK
|
TRAF family member-associated NFKB activator |
chr12_-_2986107 | 11.43 |
ENST00000359843.3
ENST00000342628.2 ENST00000361953.3 |
FOXM1
|
forkhead box M1 |
chr3_+_160117087 | 11.43 |
ENST00000357388.3
|
SMC4
|
structural maintenance of chromosomes 4 |
chr19_+_13051206 | 11.41 |
ENST00000586760.1
|
CALR
|
calreticulin |
chr1_-_193074504 | 11.40 |
ENST00000367439.3
|
GLRX2
|
glutaredoxin 2 |
chr5_+_32585605 | 11.40 |
ENST00000265073.4
ENST00000515355.1 ENST00000502897.1 ENST00000510442.1 |
SUB1
|
SUB1 homolog (S. cerevisiae) |
chr3_-_149093499 | 11.40 |
ENST00000472441.1
|
TM4SF1
|
transmembrane 4 L six family member 1 |
chr18_-_51751132 | 11.36 |
ENST00000256429.3
|
MBD2
|
methyl-CpG binding domain protein 2 |
chr12_-_56122426 | 11.32 |
ENST00000551173.1
|
CD63
|
CD63 molecule |
chrX_+_118602363 | 11.32 |
ENST00000317881.8
|
SLC25A5
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 |
chr2_+_201997595 | 11.26 |
ENST00000470178.2
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
chr1_-_19746236 | 11.23 |
ENST00000375144.1
|
CAPZB
|
capping protein (actin filament) muscle Z-line, beta |
chr6_+_24667257 | 11.22 |
ENST00000537591.1
ENST00000230048.4 |
ACOT13
|
acyl-CoA thioesterase 13 |
chr21_-_46237883 | 11.13 |
ENST00000397893.3
|
SUMO3
|
small ubiquitin-like modifier 3 |
chr12_-_76462713 | 11.05 |
ENST00000552056.1
|
NAP1L1
|
nucleosome assembly protein 1-like 1 |
chr2_-_151344172 | 11.03 |
ENST00000375734.2
ENST00000263895.4 ENST00000454202.1 |
RND3
|
Rho family GTPase 3 |
chr16_-_75681522 | 11.02 |
ENST00000568378.1
ENST00000568682.1 ENST00000570215.1 ENST00000319410.5 ENST00000302445.3 |
KARS
|
lysyl-tRNA synthetase |
chr6_-_137539651 | 10.95 |
ENST00000543628.1
|
IFNGR1
|
interferon gamma receptor 1 |
chr2_+_89923550 | 10.93 |
ENST00000509129.1
|
IGKV1D-37
|
immunoglobulin kappa variable 1D-37 (non-functional) |
chr10_+_17686124 | 10.91 |
ENST00000377524.3
|
STAM
|
signal transducing adaptor molecule (SH3 domain and ITAM motif) 1 |
chr12_+_27863706 | 10.84 |
ENST00000081029.3
ENST00000538315.1 ENST00000542791.1 |
MRPS35
|
mitochondrial ribosomal protein S35 |
chr15_-_77376269 | 10.79 |
ENST00000558745.1
|
TSPAN3
|
tetraspanin 3 |
chr15_+_89181974 | 10.78 |
ENST00000306072.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr5_-_96518907 | 10.78 |
ENST00000508447.1
ENST00000283109.3 |
RIOK2
|
RIO kinase 2 |
chr20_-_1373726 | 10.76 |
ENST00000400137.4
|
FKBP1A
|
FK506 binding protein 1A, 12kDa |
chr17_-_65362678 | 10.75 |
ENST00000357146.4
ENST00000356126.3 |
PSMD12
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 12 |
chr17_-_39681578 | 10.74 |
ENST00000593096.1
|
KRT19
|
keratin 19 |
chr12_-_50419177 | 10.73 |
ENST00000454520.2
ENST00000546595.1 ENST00000548824.1 ENST00000549777.1 ENST00000546723.1 ENST00000427314.2 ENST00000552157.1 ENST00000552310.1 ENST00000548644.1 ENST00000312377.5 ENST00000546786.1 ENST00000550149.1 ENST00000546764.1 ENST00000552004.1 ENST00000548320.1 ENST00000547905.1 ENST00000550651.1 ENST00000551145.1 ENST00000434422.1 ENST00000552921.1 |
RACGAP1
|
Rac GTPase activating protein 1 |
chr1_+_45477819 | 10.71 |
ENST00000246337.4
|
UROD
|
uroporphyrinogen decarboxylase |
chr2_+_216974020 | 10.64 |
ENST00000392132.2
ENST00000417391.1 |
XRCC5
|
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining) |
chr1_-_246580705 | 10.64 |
ENST00000541742.1
|
SMYD3
|
SET and MYND domain containing 3 |
chr1_+_53392901 | 10.62 |
ENST00000371514.3
ENST00000528311.1 ENST00000371509.4 ENST00000407246.2 ENST00000371513.5 |
SCP2
|
sterol carrier protein 2 |
chr2_-_113594279 | 10.62 |
ENST00000416750.1
ENST00000418817.1 ENST00000263341.2 |
IL1B
|
interleukin 1, beta |
chr12_-_56122761 | 10.59 |
ENST00000552164.1
ENST00000420846.3 ENST00000257857.4 |
CD63
|
CD63 molecule |
chr1_-_109968973 | 10.53 |
ENST00000271308.4
ENST00000538610.1 |
PSMA5
|
proteasome (prosome, macropain) subunit, alpha type, 5 |
chrX_-_109561294 | 10.51 |
ENST00000372059.2
ENST00000262844.5 |
AMMECR1
|
Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 |
chr12_-_48099754 | 10.51 |
ENST00000380650.4
|
RPAP3
|
RNA polymerase II associated protein 3 |
chr12_+_16109519 | 10.44 |
ENST00000526530.1
|
DERA
|
deoxyribose-phosphate aldolase (putative) |
chr3_+_133293278 | 10.44 |
ENST00000508481.1
ENST00000420115.2 ENST00000504867.1 ENST00000507408.1 ENST00000511392.1 ENST00000515421.1 |
CDV3
|
CDV3 homolog (mouse) |
chr12_-_48099773 | 10.36 |
ENST00000432584.3
ENST00000005386.3 |
RPAP3
|
RNA polymerase II associated protein 3 |
chr11_-_104817919 | 10.35 |
ENST00000533252.1
|
CASP4
|
caspase 4, apoptosis-related cysteine peptidase |
chr5_-_10761206 | 10.32 |
ENST00000432074.2
ENST00000230895.6 |
DAP
|
death-associated protein |
chr3_+_183894566 | 10.23 |
ENST00000439647.1
|
AP2M1
|
adaptor-related protein complex 2, mu 1 subunit |
chr2_-_89459813 | 10.23 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
chr9_+_71820057 | 10.23 |
ENST00000539225.1
|
TJP2
|
tight junction protein 2 |
chr2_+_89998789 | 10.20 |
ENST00000453166.2
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
chrX_-_77225135 | 10.18 |
ENST00000458128.1
|
PGAM4
|
phosphoglycerate mutase family member 4 |
chr7_+_128379346 | 10.13 |
ENST00000535011.2
ENST00000542996.2 ENST00000535623.1 ENST00000538546.1 ENST00000249364.4 ENST00000449187.2 |
CALU
|
calumenin |
chr15_-_59225758 | 10.11 |
ENST00000558486.1
ENST00000560682.1 ENST00000249736.7 ENST00000559880.1 ENST00000536328.1 |
SLTM
|
SAFB-like, transcription modulator |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
22.5 | 90.0 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
11.3 | 33.9 | GO:0002661 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
8.4 | 25.2 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
8.3 | 25.0 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
7.7 | 38.6 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
7.4 | 29.6 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
7.1 | 21.4 | GO:1900138 | negative regulation of phospholipase A2 activity(GO:1900138) |
6.8 | 27.2 | GO:0006218 | uridine catabolic process(GO:0006218) uridine metabolic process(GO:0046108) |
6.2 | 18.6 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
6.0 | 18.1 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
6.0 | 17.9 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
5.9 | 23.8 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
5.9 | 17.8 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
5.9 | 23.4 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
5.7 | 28.5 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
5.5 | 32.9 | GO:0022614 | membrane to membrane docking(GO:0022614) |
5.4 | 27.2 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
5.4 | 16.2 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
5.4 | 16.2 | GO:0002188 | translation reinitiation(GO:0002188) |
5.3 | 74.0 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
5.2 | 15.5 | GO:0070638 | nicotinamide riboside catabolic process(GO:0006738) inosine metabolic process(GO:0046102) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
5.0 | 49.5 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
4.8 | 24.1 | GO:0007619 | courtship behavior(GO:0007619) |
4.8 | 14.3 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
4.6 | 13.8 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
4.5 | 13.5 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
4.4 | 22.1 | GO:0015862 | uridine transport(GO:0015862) |
4.4 | 13.1 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
4.2 | 12.5 | GO:0051097 | negative regulation of helicase activity(GO:0051097) oxidative stress-induced premature senescence(GO:0090403) oligodendrocyte apoptotic process(GO:0097252) |
4.1 | 24.8 | GO:0007296 | vitellogenesis(GO:0007296) |
4.1 | 12.2 | GO:1902310 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
4.0 | 4.0 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
3.9 | 15.6 | GO:0071461 | cellular response to redox state(GO:0071461) |
3.7 | 18.7 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
3.7 | 48.4 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
3.6 | 25.3 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
3.6 | 18.0 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
3.5 | 10.6 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
3.5 | 10.6 | GO:0060557 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
3.4 | 10.3 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
3.4 | 13.7 | GO:0014040 | positive regulation of Schwann cell differentiation(GO:0014040) |
3.3 | 13.4 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
3.3 | 10.0 | GO:0007518 | myoblast fate determination(GO:0007518) |
3.3 | 13.4 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
3.3 | 19.8 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
3.3 | 16.3 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
3.2 | 12.7 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
3.0 | 15.1 | GO:0033383 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
3.0 | 21.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
2.9 | 8.8 | GO:1904933 | cardiac right atrium morphogenesis(GO:0003213) negative regulation of melanin biosynthetic process(GO:0048022) positive regulation of anagen(GO:0051885) mediolateral intercalation(GO:0060031) cervix development(GO:0060067) lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) negative regulation of secondary metabolite biosynthetic process(GO:1900377) regulation of cell proliferation in midbrain(GO:1904933) |
2.9 | 8.7 | GO:0033341 | regulation of collagen binding(GO:0033341) |
2.8 | 8.5 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
2.8 | 2.8 | GO:0043335 | protein unfolding(GO:0043335) |
2.7 | 35.1 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
2.6 | 15.9 | GO:2000334 | blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
2.6 | 7.9 | GO:0052027 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
2.6 | 47.2 | GO:0001765 | membrane raft assembly(GO:0001765) |
2.6 | 10.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
2.6 | 7.8 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
2.6 | 51.7 | GO:0006465 | signal peptide processing(GO:0006465) |
2.6 | 7.7 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
2.5 | 10.2 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
2.4 | 24.5 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
2.4 | 36.6 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
2.4 | 31.7 | GO:0019388 | galactose catabolic process(GO:0019388) |
2.4 | 7.3 | GO:0070541 | response to platinum ion(GO:0070541) |
2.4 | 41.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
2.3 | 42.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
2.3 | 14.0 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
2.3 | 9.3 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
2.3 | 23.3 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
2.3 | 6.9 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
2.3 | 9.1 | GO:0032072 | plasmacytoid dendritic cell activation(GO:0002270) T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
2.2 | 11.2 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
2.2 | 22.4 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
2.2 | 11.2 | GO:0002084 | protein depalmitoylation(GO:0002084) |
2.2 | 8.8 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
2.2 | 8.8 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
2.2 | 41.4 | GO:0016540 | protein autoprocessing(GO:0016540) |
2.2 | 8.7 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
2.1 | 6.4 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
2.1 | 6.3 | GO:1900368 | regulation of RNA interference(GO:1900368) negative regulation of RNA interference(GO:1900369) |
2.1 | 10.5 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
2.1 | 8.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
2.1 | 18.7 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
2.0 | 4.0 | GO:1990523 | bone regeneration(GO:1990523) |
2.0 | 15.9 | GO:0042761 | fatty acid elongation(GO:0030497) very long-chain fatty acid biosynthetic process(GO:0042761) |
2.0 | 11.9 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
2.0 | 7.8 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
1.9 | 17.5 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
1.9 | 3.8 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
1.9 | 5.7 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
1.9 | 7.6 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
1.9 | 11.3 | GO:1901029 | adenine transport(GO:0015853) negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
1.9 | 18.9 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
1.9 | 5.6 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
1.9 | 27.8 | GO:0006089 | lactate metabolic process(GO:0006089) |
1.8 | 10.9 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
1.8 | 7.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
1.8 | 5.3 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.7 | 19.1 | GO:0002934 | desmosome organization(GO:0002934) |
1.7 | 18.9 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
1.7 | 33.7 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
1.7 | 20.2 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
1.7 | 5.0 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
1.7 | 11.6 | GO:0035897 | proteolysis in other organism(GO:0035897) |
1.7 | 19.9 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
1.7 | 9.9 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
1.6 | 8.2 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) positive regulation of autophagosome maturation(GO:1901098) |
1.6 | 8.2 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
1.6 | 4.9 | GO:0034471 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
1.6 | 17.7 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
1.6 | 6.4 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
1.6 | 12.8 | GO:0006983 | ER overload response(GO:0006983) |
1.6 | 12.8 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
1.6 | 9.6 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
1.6 | 7.9 | GO:0050668 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) positive regulation of homocysteine metabolic process(GO:0050668) |
1.6 | 3.2 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
1.6 | 4.7 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
1.6 | 4.7 | GO:0043602 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) |
1.6 | 18.7 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
1.6 | 6.2 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
1.6 | 4.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.5 | 4.6 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
1.5 | 9.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
1.5 | 68.8 | GO:2000816 | negative regulation of mitotic sister chromatid separation(GO:2000816) |
1.5 | 1.5 | GO:0006267 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
1.5 | 9.1 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
1.5 | 132.4 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
1.5 | 7.5 | GO:0018158 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) protein oxidation(GO:0018158) |
1.5 | 5.9 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
1.5 | 23.8 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
1.5 | 4.4 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
1.5 | 11.8 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
1.4 | 11.4 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
1.4 | 5.7 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
1.4 | 15.6 | GO:0038203 | TORC2 signaling(GO:0038203) |
1.4 | 2.8 | GO:0051834 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
1.4 | 12.6 | GO:0030091 | protein repair(GO:0030091) |
1.4 | 8.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
1.4 | 58.1 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
1.4 | 16.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
1.4 | 5.5 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
1.4 | 9.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
1.4 | 4.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
1.3 | 13.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
1.3 | 16.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
1.3 | 4.0 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
1.3 | 7.9 | GO:0036490 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) negative regulation of PERK-mediated unfolded protein response(GO:1903898) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
1.3 | 7.9 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
1.3 | 30.1 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
1.3 | 9.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
1.3 | 20.7 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
1.3 | 10.3 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.3 | 3.9 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
1.3 | 54.8 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
1.3 | 11.4 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
1.3 | 205.3 | GO:0002377 | immunoglobulin production(GO:0002377) |
1.3 | 6.3 | GO:1902775 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
1.3 | 6.3 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
1.3 | 7.5 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
1.2 | 5.0 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
1.2 | 5.0 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
1.2 | 9.8 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
1.2 | 16.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
1.2 | 4.9 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
1.2 | 13.4 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
1.2 | 4.8 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
1.2 | 7.1 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
1.2 | 7.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.2 | 5.9 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
1.2 | 3.5 | GO:0060380 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) positive regulation of telomeric DNA binding(GO:1904744) |
1.2 | 3.5 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
1.1 | 5.7 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
1.1 | 4.6 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
1.1 | 11.4 | GO:0042262 | DNA protection(GO:0042262) |
1.1 | 6.8 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
1.1 | 11.3 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
1.1 | 32.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.1 | 12.0 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
1.1 | 5.4 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
1.1 | 6.4 | GO:0090191 | negative regulation of mesonephros development(GO:0061218) negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
1.1 | 3.2 | GO:0099553 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
1.1 | 6.3 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
1.0 | 4.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
1.0 | 4.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
1.0 | 7.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
1.0 | 4.1 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.0 | 11.0 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
1.0 | 20.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
1.0 | 1.0 | GO:1903436 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
1.0 | 7.6 | GO:0042407 | cristae formation(GO:0042407) |
1.0 | 6.7 | GO:0046348 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.9 | 1.9 | GO:0032679 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
0.9 | 3.8 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.9 | 4.6 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.9 | 68.0 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.9 | 2.7 | GO:0052148 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
0.9 | 12.7 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.9 | 4.5 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.9 | 3.6 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
0.9 | 11.6 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.9 | 8.8 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.9 | 8.8 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.9 | 3.5 | GO:0048254 | snoRNA localization(GO:0048254) |
0.9 | 4.3 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.9 | 4.3 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.9 | 7.7 | GO:2000507 | cap-dependent translational initiation(GO:0002191) positive regulation of energy homeostasis(GO:2000507) |
0.9 | 19.6 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.8 | 5.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.8 | 10.7 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.8 | 50.6 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.8 | 131.0 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.8 | 19.2 | GO:0006293 | nucleotide-excision repair, preincision complex stabilization(GO:0006293) nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.8 | 24.0 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.8 | 2.4 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.8 | 3.1 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.8 | 8.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.7 | 5.9 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.7 | 6.7 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.7 | 2.2 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.7 | 2.2 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.7 | 0.7 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.7 | 2.1 | GO:1990169 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) stress response to copper ion(GO:1990169) |
0.7 | 6.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.7 | 14.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.7 | 2.1 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.7 | 3.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.7 | 10.1 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.7 | 3.4 | GO:0015840 | urea transport(GO:0015840) |
0.7 | 2.0 | GO:0042351 | GDP-L-fucose biosynthetic process(GO:0042350) 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.7 | 3.4 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.6 | 5.1 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.6 | 4.5 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.6 | 3.2 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
0.6 | 2.6 | GO:0021564 | vagus nerve development(GO:0021564) |
0.6 | 3.8 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.6 | 6.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.6 | 16.8 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
0.6 | 4.8 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.6 | 11.4 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.6 | 41.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.6 | 17.0 | GO:0048846 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
0.6 | 2.9 | GO:0051693 | actin filament capping(GO:0051693) |
0.6 | 2.3 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.6 | 5.7 | GO:0006974 | cellular response to DNA damage stimulus(GO:0006974) |
0.6 | 11.4 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.6 | 5.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.6 | 4.6 | GO:0050747 | sphingomyelin biosynthetic process(GO:0006686) positive regulation of lipoprotein metabolic process(GO:0050747) |
0.6 | 1.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.6 | 5.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.6 | 13.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.6 | 7.8 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.6 | 15.4 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
0.5 | 2.7 | GO:0060356 | leucine import(GO:0060356) |
0.5 | 40.1 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.5 | 2.1 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.5 | 10.0 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.5 | 7.3 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.5 | 6.7 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.5 | 9.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.5 | 5.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.5 | 13.1 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.5 | 13.1 | GO:0006625 | protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.5 | 6.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.5 | 4.4 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.5 | 12.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.5 | 1.5 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.5 | 1.5 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) valyl-tRNA aminoacylation(GO:0006438) |
0.5 | 2.4 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.5 | 1.9 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.5 | 1.0 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
0.5 | 4.3 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
0.5 | 10.0 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.5 | 5.2 | GO:0003373 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.5 | 1.4 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.5 | 8.7 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.5 | 26.0 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.5 | 1.4 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.4 | 41.4 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.4 | 34.0 | GO:0070527 | platelet aggregation(GO:0070527) |
0.4 | 3.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.4 | 15.0 | GO:0006363 | transcription elongation from RNA polymerase I promoter(GO:0006362) termination of RNA polymerase I transcription(GO:0006363) |
0.4 | 12.8 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.4 | 8.7 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.4 | 1.3 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.4 | 7.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.4 | 14.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.4 | 22.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.4 | 2.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.4 | 17.2 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.4 | 5.5 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.4 | 25.5 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.4 | 1.3 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.4 | 0.8 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.4 | 13.8 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.4 | 2.8 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.4 | 1.2 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.4 | 2.8 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.4 | 2.4 | GO:0030421 | defecation(GO:0030421) |
0.4 | 15.8 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.4 | 1.6 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.4 | 2.3 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.4 | 9.0 | GO:0000732 | strand displacement(GO:0000732) |
0.4 | 0.8 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
0.4 | 17.8 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.4 | 1.5 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.4 | 1.1 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.4 | 1.5 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.4 | 1.1 | GO:1901656 | glycoside transport(GO:1901656) |
0.4 | 16.9 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.4 | 1.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.4 | 1.1 | GO:0051685 | maintenance of ER location(GO:0051685) |
0.4 | 16.3 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.4 | 6.1 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.4 | 1.8 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.4 | 0.7 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.3 | 1.0 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.3 | 10.3 | GO:0002576 | platelet degranulation(GO:0002576) |
0.3 | 1.4 | GO:0001545 | primary ovarian follicle growth(GO:0001545) |
0.3 | 1.7 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.3 | 5.0 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.3 | 35.6 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.3 | 5.3 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.3 | 8.2 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.3 | 3.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.3 | 9.1 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.3 | 5.2 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.3 | 15.1 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.3 | 5.4 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 1.3 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.3 | 7.2 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.3 | 1.9 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.3 | 3.4 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.3 | 1.2 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.3 | 5.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.3 | 0.9 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.3 | 3.0 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.3 | 1.8 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.3 | 3.2 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.3 | 4.7 | GO:0051014 | actin filament severing(GO:0051014) |
0.3 | 3.7 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.3 | 1.7 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) arterial endothelial cell differentiation(GO:0060842) |
0.3 | 15.5 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.3 | 1.9 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.3 | 7.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.3 | 4.6 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.3 | 5.6 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.3 | 1.1 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.3 | 0.8 | GO:0071724 | toll-like receptor TLR6:TLR2 signaling pathway(GO:0038124) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
0.3 | 1.8 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.3 | 30.8 | GO:0006302 | double-strand break repair(GO:0006302) |
0.3 | 4.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.3 | 5.7 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.3 | 1.5 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.3 | 3.1 | GO:0036258 | multivesicular body organization(GO:0036257) multivesicular body assembly(GO:0036258) |
0.3 | 6.4 | GO:0090383 | phagosome acidification(GO:0090383) |
0.3 | 5.8 | GO:0014904 | myotube cell development(GO:0014904) |
0.3 | 3.5 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.3 | 2.0 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.2 | 10.0 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.2 | 4.7 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.2 | 6.2 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.2 | 1.7 | GO:0044346 | fibroblast apoptotic process(GO:0044346) regulation of fibroblast apoptotic process(GO:2000269) positive regulation of fibroblast apoptotic process(GO:2000271) |
0.2 | 5.2 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.2 | 3.4 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.2 | 8.3 | GO:0032570 | response to progesterone(GO:0032570) |
0.2 | 0.7 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
0.2 | 7.6 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.2 | 2.8 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.2 | 2.1 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.2 | 0.5 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.2 | 1.4 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.2 | 1.6 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.2 | 1.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 2.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.2 | 2.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.2 | 1.8 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.2 | 6.5 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.2 | 2.4 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 1.3 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.2 | 3.7 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.2 | 3.3 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.2 | 9.9 | GO:0006414 | translational elongation(GO:0006414) |
0.2 | 9.6 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 4.3 | GO:0042438 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.2 | 12.8 | GO:0002223 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
0.2 | 2.6 | GO:0036475 | neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced neuron death(GO:1903203) negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.2 | 19.3 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.2 | 1.4 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.2 | 55.7 | GO:0008380 | RNA splicing(GO:0008380) |
0.2 | 1.9 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 0.4 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.2 | 5.0 | GO:0010761 | fibroblast migration(GO:0010761) |
0.2 | 6.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.2 | 18.1 | GO:0070268 | cornification(GO:0070268) |
0.2 | 0.2 | GO:2000192 | negative regulation of icosanoid secretion(GO:0032304) negative regulation of fatty acid transport(GO:2000192) |
0.2 | 6.3 | GO:0035329 | hippo signaling(GO:0035329) |
0.2 | 1.2 | GO:1903209 | positive regulation of oxidative stress-induced cell death(GO:1903209) |
0.2 | 7.9 | GO:0046324 | regulation of glucose import(GO:0046324) |
0.2 | 4.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 3.6 | GO:0051972 | regulation of telomerase activity(GO:0051972) |
0.2 | 1.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 2.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 1.3 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
0.2 | 3.6 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.2 | 1.9 | GO:0031214 | biomineral tissue development(GO:0031214) |
0.2 | 11.2 | GO:0051225 | spindle assembly(GO:0051225) |
0.2 | 2.2 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.2 | 0.8 | GO:0022900 | electron transport chain(GO:0022900) |
0.2 | 1.3 | GO:0097190 | apoptotic signaling pathway(GO:0097190) |
0.2 | 0.5 | GO:0002818 | intracellular defense response(GO:0002818) |
0.2 | 1.2 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.2 | 1.1 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.1 | 0.7 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 2.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.9 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 1.7 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.8 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.1 | 0.4 | GO:0051801 | cytolysis by symbiont of host cells(GO:0001897) hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) cytolysis in other organism involved in symbiotic interaction(GO:0051801) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.1 | 1.9 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 1.7 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 1.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.1 | 2.8 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.1 | 1.6 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.2 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.1 | 1.6 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.1 | 1.6 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 1.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 1.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 3.4 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.1 | 5.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.7 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 1.0 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.1 | 1.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 2.0 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.1 | 0.4 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.1 | 1.4 | GO:0007567 | parturition(GO:0007567) |
0.1 | 1.8 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 2.3 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.1 | 1.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 1.0 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.6 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.1 | 0.5 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.1 | 0.5 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.1 | 0.8 | GO:0000075 | cell cycle checkpoint(GO:0000075) |
0.1 | 4.3 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.2 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.1 | 0.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.3 | GO:2001189 | negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001189) |
0.1 | 0.3 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.4 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.1 | 6.3 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
0.1 | 0.4 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.9 | GO:0010458 | exit from mitosis(GO:0010458) |
0.1 | 0.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.5 | GO:0032445 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.1 | 0.7 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.3 | GO:0015691 | cadmium ion transport(GO:0015691) lead ion transport(GO:0015692) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 1.1 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.7 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.6 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.0 | 0.9 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 1.3 | GO:0043525 | positive regulation of neuron apoptotic process(GO:0043525) |
0.0 | 4.2 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.0 | 1.1 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.0 | 0.2 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.3 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.8 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.5 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.9 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.0 | 0.9 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.6 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 1.4 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.6 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 1.3 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 0.1 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.1 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 0.1 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.0 | 0.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.5 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.8 | GO:0051604 | protein maturation(GO:0051604) |
0.0 | 2.9 | GO:0051170 | nuclear import(GO:0051170) |
0.0 | 3.5 | GO:0006260 | DNA replication(GO:0006260) |
0.0 | 0.4 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.0 | 0.6 | GO:0030282 | bone mineralization(GO:0030282) |
0.0 | 0.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.1 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.0 | 0.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.0 | 9.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
7.5 | 30.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
7.4 | 51.7 | GO:0005787 | signal peptidase complex(GO:0005787) |
5.9 | 29.6 | GO:0097149 | centralspindlin complex(GO:0097149) |
5.0 | 25.2 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
4.8 | 24.1 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
4.8 | 33.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
4.7 | 14.0 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
4.6 | 55.7 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
4.6 | 73.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
4.6 | 13.7 | GO:0071159 | NF-kappaB complex(GO:0071159) |
4.5 | 13.4 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
4.3 | 38.6 | GO:0005638 | lamin filament(GO:0005638) |
4.2 | 12.7 | GO:0044393 | microspike(GO:0044393) |
4.1 | 16.3 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
4.0 | 24.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
3.8 | 42.0 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
3.8 | 33.9 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
3.4 | 51.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
3.3 | 16.6 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
3.2 | 25.9 | GO:0005610 | laminin-5 complex(GO:0005610) |
2.9 | 52.3 | GO:0097342 | ripoptosome(GO:0097342) |
2.6 | 36.4 | GO:0031209 | SCAR complex(GO:0031209) |
2.6 | 31.0 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
2.5 | 20.2 | GO:0034715 | U7 snRNP(GO:0005683) pICln-Sm protein complex(GO:0034715) |
2.5 | 24.7 | GO:0097255 | R2TP complex(GO:0097255) |
2.5 | 2.5 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
2.4 | 14.7 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
2.4 | 17.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
2.4 | 29.1 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
2.4 | 7.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
2.4 | 14.2 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
2.2 | 24.4 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
2.2 | 19.8 | GO:0070652 | HAUS complex(GO:0070652) |
2.2 | 8.7 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
2.2 | 28.2 | GO:0097433 | dense body(GO:0097433) |
2.1 | 10.6 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
2.0 | 43.0 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
2.0 | 8.0 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
1.9 | 15.2 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) cytosolic proteasome complex(GO:0031597) |
1.9 | 11.3 | GO:0071817 | MMXD complex(GO:0071817) |
1.9 | 9.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
1.8 | 33.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
1.8 | 12.7 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
1.8 | 21.5 | GO:0005915 | zonula adherens(GO:0005915) |
1.8 | 10.7 | GO:1990357 | terminal web(GO:1990357) |
1.8 | 7.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
1.7 | 13.9 | GO:0034719 | SMN-Sm protein complex(GO:0034719) Gemini of coiled bodies(GO:0097504) |
1.7 | 6.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.7 | 13.8 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.7 | 6.9 | GO:0032449 | CBM complex(GO:0032449) |
1.7 | 9.9 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
1.6 | 4.9 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
1.6 | 12.7 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
1.6 | 6.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.5 | 6.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
1.5 | 6.0 | GO:0000811 | GINS complex(GO:0000811) |
1.3 | 10.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
1.3 | 10.5 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
1.3 | 14.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
1.3 | 6.4 | GO:0000125 | PCAF complex(GO:0000125) |
1.3 | 3.8 | GO:0031415 | NatA complex(GO:0031415) |
1.3 | 6.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.3 | 7.6 | GO:1904724 | tertiary granule lumen(GO:1904724) |
1.2 | 19.7 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
1.2 | 3.6 | GO:0034455 | t-UTP complex(GO:0034455) |
1.2 | 14.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.1 | 11.4 | GO:0000796 | condensin complex(GO:0000796) |
1.1 | 21.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
1.1 | 20.7 | GO:0036020 | endolysosome membrane(GO:0036020) |
1.1 | 7.6 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
1.1 | 7.6 | GO:0061617 | MICOS complex(GO:0061617) |
1.1 | 59.8 | GO:0016235 | aggresome(GO:0016235) |
1.0 | 27.9 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
1.0 | 7.1 | GO:0000812 | Swr1 complex(GO:0000812) |
1.0 | 6.0 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
1.0 | 7.8 | GO:0033391 | chromatoid body(GO:0033391) |
1.0 | 3.9 | GO:0032010 | phagolysosome(GO:0032010) |
1.0 | 36.4 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
1.0 | 15.3 | GO:0071437 | invadopodium(GO:0071437) |
1.0 | 17.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.9 | 8.4 | GO:0044754 | autolysosome(GO:0044754) |
0.9 | 4.6 | GO:0030891 | VCB complex(GO:0030891) |
0.9 | 3.6 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.9 | 16.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.9 | 13.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.9 | 3.5 | GO:0005687 | U4 snRNP(GO:0005687) |
0.9 | 15.6 | GO:0031932 | TORC2 complex(GO:0031932) |
0.9 | 12.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.9 | 3.4 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.9 | 85.9 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.8 | 25.8 | GO:0030057 | desmosome(GO:0030057) |
0.8 | 7.5 | GO:0097413 | Lewy body(GO:0097413) |
0.8 | 9.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.8 | 20.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.8 | 12.1 | GO:0001741 | XY body(GO:0001741) |
0.8 | 8.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.8 | 4.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.8 | 2.3 | GO:0031982 | vesicle(GO:0031982) |
0.8 | 9.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.8 | 4.6 | GO:0031526 | brush border membrane(GO:0031526) |
0.8 | 21.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.7 | 7.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.7 | 79.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.7 | 122.2 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.7 | 5.2 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.7 | 14.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.7 | 12.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.7 | 17.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.7 | 11.3 | GO:0043231 | intracellular membrane-bounded organelle(GO:0043231) |
0.7 | 19.8 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.7 | 20.3 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.7 | 4.8 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.7 | 21.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.6 | 7.8 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.6 | 2.6 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.6 | 2.6 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.6 | 9.5 | GO:0005686 | U2 snRNP(GO:0005686) |
0.6 | 28.7 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.6 | 73.3 | GO:0005840 | ribosome(GO:0005840) |
0.6 | 18.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.6 | 4.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.6 | 12.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.6 | 7.7 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.6 | 33.8 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.6 | 6.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.5 | 5.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.5 | 13.4 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.5 | 1.6 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.5 | 5.2 | GO:0010369 | chromocenter(GO:0010369) |
0.5 | 1.0 | GO:0031528 | microvillus membrane(GO:0031528) |
0.5 | 4.6 | GO:0061574 | ASAP complex(GO:0061574) |
0.5 | 17.1 | GO:0032420 | stereocilium(GO:0032420) |
0.5 | 62.9 | GO:0016605 | PML body(GO:0016605) |
0.5 | 2.5 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.5 | 3.4 | GO:0005652 | nuclear lamina(GO:0005652) |
0.5 | 1.0 | GO:0042627 | chylomicron(GO:0042627) |
0.5 | 8.3 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.4 | 1.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 1.3 | GO:0036398 | TCR signalosome(GO:0036398) |
0.4 | 3.0 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.4 | 15.9 | GO:0016592 | mediator complex(GO:0016592) |
0.4 | 21.3 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.4 | 1.7 | GO:0035838 | growing cell tip(GO:0035838) |
0.4 | 5.8 | GO:0008091 | spectrin(GO:0008091) |
0.4 | 2.1 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.4 | 21.9 | GO:0035580 | specific granule lumen(GO:0035580) |
0.4 | 1.2 | GO:0097679 | other organism cytoplasm(GO:0097679) |
0.4 | 20.7 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.4 | 37.2 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.4 | 1.6 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.4 | 2.7 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.4 | 0.8 | GO:0001940 | male pronucleus(GO:0001940) |
0.4 | 5.0 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.4 | 4.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.4 | 1.1 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.4 | 3.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 2.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.4 | 6.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.4 | 42.9 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.4 | 1.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) CNTFR-CLCF1 complex(GO:0097059) |
0.4 | 1.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.3 | 14.9 | GO:0005876 | spindle microtubule(GO:0005876) |
0.3 | 2.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.3 | 3.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.3 | 27.3 | GO:0034707 | chloride channel complex(GO:0034707) |
0.3 | 16.2 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.3 | 1.0 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.3 | 14.8 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.3 | 1.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 4.1 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.3 | 6.5 | GO:0031105 | septin complex(GO:0031105) |
0.3 | 4.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.3 | 21.1 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.3 | 4.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.3 | 5.0 | GO:0031045 | dense core granule(GO:0031045) |
0.3 | 17.0 | GO:0000792 | heterochromatin(GO:0000792) |
0.3 | 8.8 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.3 | 13.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 0.7 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.2 | 1.5 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
0.2 | 10.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 27.2 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 35.9 | GO:0000793 | condensed chromosome(GO:0000793) |
0.2 | 129.0 | GO:0016604 | nuclear body(GO:0016604) |
0.2 | 4.9 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.2 | 1.8 | GO:0035976 | AP1 complex(GO:0035976) |
0.2 | 4.9 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.2 | 23.1 | GO:0034399 | nuclear periphery(GO:0034399) |
0.2 | 2.1 | GO:0070069 | cytochrome complex(GO:0070069) |
0.2 | 1.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 1.5 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.2 | 7.6 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 0.7 | GO:1990812 | growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
0.2 | 98.2 | GO:0070161 | anchoring junction(GO:0070161) |
0.2 | 10.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 0.7 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 8.4 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 4.1 | GO:0044217 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.2 | 10.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 0.5 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.2 | 12.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 10.0 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 11.3 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 1.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 1.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 2.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 3.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 33.5 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 4.4 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.5 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.1 | 2.9 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.1 | 3.8 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 1.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 1.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.9 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 2.4 | GO:0098800 | inner mitochondrial membrane protein complex(GO:0098800) |
0.1 | 5.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 18.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 1.6 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.3 | GO:0070826 | paraferritin complex(GO:0070826) |
0.0 | 11.7 | GO:0005635 | nuclear envelope(GO:0005635) |
0.0 | 0.9 | GO:0030425 | dendrite(GO:0030425) |
0.0 | 0.3 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 2.4 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 51.1 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.2 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 1.1 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 0.2 | GO:0034774 | secretory granule lumen(GO:0034774) |
0.0 | 0.1 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.0 | 0.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.4 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.0 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 0.1 | GO:0036157 | outer dynein arm(GO:0036157) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.8 | 50.5 | GO:0036317 | tyrosyl-RNA phosphodiesterase activity(GO:0036317) 5'-tyrosyl-DNA phosphodiesterase activity(GO:0070260) |
13.5 | 40.6 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
8.5 | 33.9 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
8.4 | 25.2 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
7.7 | 46.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
7.5 | 22.6 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
7.5 | 30.1 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
6.8 | 27.2 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
6.7 | 26.8 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
6.6 | 19.9 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
5.2 | 15.5 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
5.1 | 20.5 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
4.6 | 41.4 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
4.5 | 13.4 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
4.4 | 21.8 | GO:0034597 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
4.2 | 25.3 | GO:0047115 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
4.2 | 12.6 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
4.0 | 27.8 | GO:0004459 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
3.7 | 22.2 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
3.5 | 10.6 | GO:0070538 | oleic acid binding(GO:0070538) |
3.5 | 10.4 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
3.4 | 13.5 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
3.4 | 13.4 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
3.2 | 25.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
3.2 | 9.7 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
3.1 | 18.8 | GO:1990254 | keratin filament binding(GO:1990254) |
3.0 | 21.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
3.0 | 15.1 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
3.0 | 104.8 | GO:0001848 | complement binding(GO:0001848) |
2.9 | 14.4 | GO:0030614 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) |
2.8 | 82.6 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
2.8 | 8.5 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
2.8 | 11.3 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
2.7 | 21.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
2.6 | 15.9 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
2.6 | 10.4 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
2.5 | 12.7 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
2.5 | 10.2 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
2.4 | 7.3 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
2.4 | 7.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
2.4 | 19.0 | GO:0019863 | IgE binding(GO:0019863) |
2.3 | 9.2 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
2.3 | 9.1 | GO:0016936 | galactoside binding(GO:0016936) |
2.3 | 13.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
2.3 | 9.1 | GO:0043515 | kinetochore binding(GO:0043515) |
2.2 | 10.9 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
2.1 | 83.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
2.1 | 66.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
2.1 | 8.5 | GO:0052827 | inositol pentakisphosphate phosphatase activity(GO:0052827) |
2.1 | 10.5 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
2.0 | 6.1 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
2.0 | 6.1 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
2.0 | 11.9 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
2.0 | 9.8 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
2.0 | 13.7 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
2.0 | 7.8 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
1.8 | 7.1 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
1.8 | 17.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.7 | 12.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
1.7 | 5.2 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
1.7 | 12.1 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
1.7 | 5.1 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
1.7 | 50.8 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
1.7 | 18.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
1.7 | 39.8 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
1.7 | 31.4 | GO:0044548 | S100 protein binding(GO:0044548) |
1.7 | 6.6 | GO:0052795 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
1.6 | 8.2 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
1.6 | 13.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.6 | 25.7 | GO:0050786 | RAGE receptor binding(GO:0050786) |
1.6 | 6.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.6 | 4.7 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
1.5 | 26.2 | GO:0008494 | translation activator activity(GO:0008494) |
1.5 | 12.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
1.5 | 9.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
1.5 | 13.8 | GO:0035174 | histone serine kinase activity(GO:0035174) |
1.5 | 4.6 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
1.5 | 4.6 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
1.5 | 4.4 | GO:0033149 | FFAT motif binding(GO:0033149) |
1.4 | 4.3 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
1.4 | 7.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.4 | 10.0 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.4 | 16.8 | GO:0031386 | protein tag(GO:0031386) |
1.4 | 4.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
1.4 | 20.3 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
1.4 | 8.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
1.3 | 4.0 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
1.3 | 18.4 | GO:0035197 | siRNA binding(GO:0035197) |
1.3 | 22.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
1.3 | 12.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.3 | 6.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
1.3 | 12.6 | GO:0042731 | PH domain binding(GO:0042731) |
1.3 | 288.7 | GO:0003823 | antigen binding(GO:0003823) |
1.2 | 4.6 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
1.1 | 3.4 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) 3 iron, 4 sulfur cluster binding(GO:0051538) |
1.1 | 3.4 | GO:0032427 | GBD domain binding(GO:0032427) |
1.1 | 11.7 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
1.0 | 14.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.0 | 6.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.0 | 6.1 | GO:0070513 | death domain binding(GO:0070513) |
1.0 | 5.0 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
1.0 | 29.4 | GO:0070717 | poly-purine tract binding(GO:0070717) |
1.0 | 3.9 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
1.0 | 6.8 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
1.0 | 7.8 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
1.0 | 5.7 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.9 | 7.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.9 | 8.5 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.9 | 2.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.9 | 18.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.9 | 8.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.9 | 16.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.9 | 9.8 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.9 | 2.7 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.9 | 4.4 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.9 | 2.6 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.9 | 6.0 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.8 | 21.0 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.8 | 3.2 | GO:1904408 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
0.8 | 7.2 | GO:0043426 | MRF binding(GO:0043426) |
0.8 | 12.8 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.8 | 4.0 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
0.8 | 2.4 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.8 | 25.3 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.8 | 36.8 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.8 | 3.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.8 | 6.9 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.8 | 15.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.8 | 2.3 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.8 | 3.1 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.8 | 7.7 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.8 | 6.1 | GO:0008565 | protein transporter activity(GO:0008565) |
0.8 | 59.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.7 | 4.5 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.7 | 9.7 | GO:0043022 | ribosome binding(GO:0043022) |
0.7 | 12.5 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.7 | 11.8 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.7 | 2.9 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.7 | 6.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.7 | 2.8 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.7 | 13.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.7 | 22.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.7 | 7.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.7 | 5.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.7 | 4.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.7 | 19.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.7 | 4.0 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
0.7 | 11.9 | GO:0043495 | protein anchor(GO:0043495) |
0.7 | 23.6 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.6 | 33.8 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.6 | 7.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.6 | 138.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.6 | 1.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.6 | 3.7 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.6 | 9.1 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.6 | 16.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.6 | 27.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.6 | 3.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.6 | 6.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.6 | 5.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.6 | 41.1 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.6 | 2.8 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.6 | 1.7 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) NAD(P)+ nucleosidase activity(GO:0050135) |
0.6 | 2.8 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.5 | 8.2 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.5 | 6.5 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.5 | 2.1 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.5 | 17.8 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.5 | 2.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.5 | 57.5 | GO:0002020 | protease binding(GO:0002020) |
0.5 | 8.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.5 | 13.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.5 | 3.5 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.5 | 7.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.5 | 1.5 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) valine-tRNA ligase activity(GO:0004832) |
0.5 | 11.5 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.5 | 7.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.5 | 7.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.5 | 4.2 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.5 | 4.2 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.5 | 17.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.4 | 3.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.4 | 6.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.4 | 16.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.4 | 17.3 | GO:0000049 | tRNA binding(GO:0000049) |
0.4 | 2.6 | GO:0039552 | RIG-I binding(GO:0039552) |
0.4 | 13.8 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.4 | 1.3 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.4 | 3.8 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.4 | 3.8 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.4 | 25.6 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.4 | 6.3 | GO:0019843 | rRNA binding(GO:0019843) |
0.4 | 3.3 | GO:0019158 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.4 | 2.1 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
0.4 | 6.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.4 | 1.2 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.4 | 8.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.4 | 4.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 5.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.4 | 6.0 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.4 | 2.3 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.4 | 16.0 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.4 | 10.0 | GO:0031489 | myosin V binding(GO:0031489) |
0.4 | 1.9 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
0.4 | 3.0 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.4 | 4.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.4 | 10.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.4 | 1.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.4 | 5.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.4 | 4.3 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.4 | 33.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.3 | 18.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.3 | 1.4 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.3 | 1.7 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.3 | 1.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.3 | 14.0 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.3 | 5.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.3 | 3.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.3 | 15.4 | GO:0031491 | nucleosome binding(GO:0031491) |
0.3 | 1.2 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.3 | 0.9 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.3 | 0.9 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.3 | 7.7 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.3 | 0.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 4.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.3 | 15.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.3 | 5.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 2.8 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.3 | 6.4 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.3 | 7.8 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.3 | 5.3 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.3 | 1.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.3 | 0.5 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 7.0 | GO:0030506 | ankyrin binding(GO:0030506) |
0.3 | 10.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 0.8 | GO:0001847 | opsonin receptor activity(GO:0001847) peptidoglycan receptor activity(GO:0016019) |
0.3 | 1.1 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.3 | 5.9 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.3 | 14.3 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.2 | 0.5 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.2 | 3.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 38.0 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.2 | 12.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 0.7 | GO:0048030 | disaccharide binding(GO:0048030) |
0.2 | 1.9 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.2 | 1.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.2 | 1.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 1.9 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 7.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 6.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 0.8 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.2 | 2.2 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.2 | 6.3 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 1.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 3.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 4.1 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.2 | 15.5 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.2 | 1.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 4.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 2.7 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.2 | 0.4 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.2 | 0.9 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.2 | 5.3 | GO:0032451 | demethylase activity(GO:0032451) |
0.2 | 3.6 | GO:0030515 | snoRNA binding(GO:0030515) |
0.2 | 2.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 0.5 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.2 | 2.8 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 1.5 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
0.2 | 32.9 | GO:0051015 | actin filament binding(GO:0051015) |
0.2 | 20.8 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 9.1 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.2 | 5.7 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 2.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 5.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 2.6 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.9 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.1 | 6.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 1.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.4 | GO:0017129 | triglyceride binding(GO:0017129) |
0.1 | 1.0 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 1.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 2.3 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.1 | 4.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 3.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 7.1 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 4.6 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.1 | 36.8 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.1 | 1.6 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 1.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 1.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 12.7 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.5 | GO:1990459 | transferrin receptor binding(GO:1990459) leptin receptor binding(GO:1990460) |
0.1 | 0.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.7 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 6.1 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 11.8 | GO:0016758 | transferase activity, transferring hexosyl groups(GO:0016758) |
0.1 | 1.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 3.0 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 1.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 1.1 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.1 | 1.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 2.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 1.6 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.1 | 1.9 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 1.4 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 3.2 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 3.1 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 1.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 1.0 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 2.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.5 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.1 | 0.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 2.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 11.4 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.1 | 2.2 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 0.3 | GO:0015639 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) ferrous iron transmembrane transporter activity(GO:0015093) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.1 | 1.6 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 1.1 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 1.5 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.8 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 6.5 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.8 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 1.8 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 0.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.2 | GO:0016836 | carbon-oxygen lyase activity(GO:0016835) hydro-lyase activity(GO:0016836) |
0.0 | 5.3 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.0 | 0.1 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.2 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 3.4 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.1 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 1.1 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 50.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
1.6 | 3.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.4 | 2.8 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
1.3 | 69.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
1.3 | 25.2 | PID ALK2 PATHWAY | ALK2 signaling events |
1.3 | 33.9 | PID ALK1 PATHWAY | ALK1 signaling events |
1.2 | 31.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.1 | 39.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
1.1 | 25.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
1.1 | 51.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.9 | 68.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.9 | 12.7 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.9 | 116.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.8 | 19.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.8 | 46.0 | PID AURORA B PATHWAY | Aurora B signaling |
0.8 | 23.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.8 | 25.0 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.7 | 25.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.7 | 28.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.6 | 34.6 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.6 | 20.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.6 | 12.7 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.6 | 9.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.6 | 15.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.6 | 21.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.6 | 2.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.5 | 27.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.5 | 7.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.5 | 41.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.5 | 18.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.5 | 14.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.5 | 8.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.5 | 12.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.5 | 9.5 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.5 | 36.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.5 | 17.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.5 | 6.9 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.5 | 20.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.4 | 21.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.4 | 21.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.4 | 23.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.4 | 8.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.4 | 27.1 | PID E2F PATHWAY | E2F transcription factor network |
0.4 | 7.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.4 | 12.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.4 | 1.8 | ST STAT3 PATHWAY | STAT3 Pathway |
0.3 | 11.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 4.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.3 | 8.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 11.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.3 | 18.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.3 | 14.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 2.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 4.9 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 1.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.2 | 11.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 1.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 2.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 3.5 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 1.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 1.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 0.8 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 5.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 14.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 5.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 3.0 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 7.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 2.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 4.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 2.0 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 3.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 1.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 2.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 1.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.9 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 1.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 3.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.2 | PID ATM PATHWAY | ATM pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 12.5 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
3.0 | 27.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
2.9 | 11.6 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
2.9 | 48.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
2.4 | 80.6 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
2.2 | 52.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
2.1 | 23.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
1.9 | 57.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
1.8 | 32.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
1.8 | 139.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
1.7 | 50.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.7 | 24.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.7 | 33.9 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
1.6 | 55.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
1.6 | 11.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.6 | 31.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
1.5 | 18.5 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
1.5 | 40.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
1.3 | 20.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
1.3 | 48.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
1.3 | 20.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
1.2 | 26.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
1.1 | 29.3 | REACTOME KINESINS | Genes involved in Kinesins |
1.1 | 29.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.1 | 22.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
1.0 | 22.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
1.0 | 27.8 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.9 | 10.3 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.9 | 13.9 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.9 | 22.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.9 | 20.3 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.9 | 27.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.8 | 13.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.8 | 25.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.8 | 31.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.8 | 13.9 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.8 | 13.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.8 | 18.6 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.8 | 7.7 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.8 | 35.4 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.8 | 6.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.7 | 24.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.7 | 16.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.7 | 4.7 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.7 | 13.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.7 | 21.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.6 | 18.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.6 | 51.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.6 | 6.0 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.6 | 7.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.6 | 10.6 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.6 | 101.3 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.6 | 6.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.6 | 16.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.6 | 11.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.6 | 9.9 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.5 | 42.3 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.5 | 12.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.5 | 11.8 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.5 | 12.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.5 | 59.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.5 | 6.5 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.5 | 9.5 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.5 | 8.5 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.5 | 22.9 | REACTOME TRANSLATION | Genes involved in Translation |
0.5 | 12.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.4 | 7.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.4 | 9.6 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.4 | 14.0 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.4 | 4.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.4 | 54.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.4 | 19.3 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.4 | 15.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.4 | 5.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.4 | 20.1 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.4 | 6.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 46.9 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.4 | 6.0 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.4 | 4.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.4 | 8.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 2.8 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.3 | 3.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.3 | 2.1 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.3 | 4.8 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.3 | 10.2 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.3 | 6.8 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.3 | 7.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.3 | 5.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 22.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.3 | 7.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.3 | 5.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.3 | 11.3 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.3 | 17.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.3 | 9.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.3 | 5.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.3 | 9.4 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.3 | 1.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.3 | 5.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.3 | 7.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 6.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 6.5 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.2 | 2.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 10.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 3.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 13.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 1.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 5.9 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 10.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.2 | 0.4 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.2 | 2.8 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 4.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 12.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 1.0 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 4.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 2.5 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.2 | 3.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 8.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 3.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 2.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 5.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 1.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 4.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 2.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 7.4 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 3.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.0 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.6 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 1.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 1.5 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 3.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.1 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.0 | 0.9 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |